Skip to main content
Log in

Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The effect of low dose prednisone on calcium and bone metabolism was evaluated in 8 healthy, young, male volunteers. Sodium and calcium intake were kept stable during the whole study period of 7 weeks. Week 0 was the baseline period; during week 1, 3 and 5 prednisone (10 mg/day) was given, during week 3 together with 500 mg elementary calcium and during week 5 with 4000 IU vitamin D on alternate days. During week 2, 4 and 6 no medication was given. No changes occurred in fasting urinary excretion of calcium or hydroxyproline, nor in serum levels of alkaline phosphatase, 25-Vitamin D, PTH, creatinine and inorganic phosphorus. A rapid decrease of serum osteocalcin during prednisone intake was found (p<0.01). This dip also occurred during prednisone and vitamin D treatment, but did not occur when calcium was added to prednisone, although the baseline value was lower at the start of combined treatment with prednisone and calcium. Serum calcium decreased during prednisone (p<0.05), but when prednisone was given together with calcium, an increase of serum calcium was found. (p<0.05).

It is concluded that 10 mg prednisone/day decreases bone formation, as shown by its effect on osteocalcin, while no influence is seen on bone resorption. Thus, prednisone, even when used in low doses, influences bone metabolism by uncoupling bone formation (decreased) and bone resorption (unchanged). These data suggest that the Cs-associated decrease in serum osteocalcin and in serum calcium does not occur during calcium suppletion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weiss, M.M., Corticosteroids in rheumatoid arthritis. Semin Arthritis Rheum 1989, 19, 9–21.

    PubMed  Google Scholar 

  2. Barnes, P.J. A new approach to the treatment of asthma. New Engl J Med 1989, 321, 1517–1527.

    PubMed  Google Scholar 

  3. Caldwell, J.R., Furst, D. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Sem Arthritis Rheum 1991, 21, 1–11.

    Google Scholar 

  4. Dyckman, T.R., Gluck, O.S., Murphy, W.A., Hahn, T.J., Hahn, B.H. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985, 28, 361–368.

    PubMed  Google Scholar 

  5. Ruegsegger, P., Medici, T.C., Anliker, M. Corticosteroid-induced bone loss. A longitudinal study in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983, 25, 615–620.

    PubMed  Google Scholar 

  6. Adinoff, A.D., Hollister, J.R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983, 309, 265–268.

    PubMed  Google Scholar 

  7. Hahn, T.J., Halstead, L.R., Teitelbaum, S.L. Hahn, B.H. Altered mineral metabolism in glucocorticoid-induced osteopenia. J Clin Invest 1979, 64, 655–665.

    PubMed  Google Scholar 

  8. Klein, R.G., Arnaud, S.B., Gallagher, J.C., DeLuca, H.F., Riggs, B.L. Intestinal calcium absorption in exogenous hypercortisonism. J Clin Invest 1977, 60, 253–259.

    PubMed  Google Scholar 

  9. Suzuki, Y., Ichikawa, Y., Saito, E., Homma, M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983, 32, 151–156.

    PubMed  Google Scholar 

  10. Jee, W.S.S., Park, H.Z., Roberts, W.E., Kenner, G.H. Corticosteroid and bone. Am J Anat 1970, 29, 477.

    Google Scholar 

  11. Dietrich, J.W., Canalis, E.M., Maine, D.M., Raisz, G. Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 1979, 104, 715–721.

    PubMed  Google Scholar 

  12. Lukert, B.P., Raisz, L.G. Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990, 112, 352–364.

    PubMed  Google Scholar 

  13. Reid, I.R. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinology 1989, 30, 83–103.

    Google Scholar 

  14. Silverman, S.L. Management of corticosteroid-induced osteoporosis: a clinician's perspective. Calcif Tissue Int 1992, 50, 101–103.

    PubMed  Google Scholar 

  15. Garton, M.J., Reid, D.M., Bone mineral density of the hip and of the anteroposterior and lateral dimensions of the spine in men with rheumatoid arthritis. Arthritis Rheum 1993, 36, 222–227.

    PubMed  Google Scholar 

  16. Laan, R.F.J.M., van Riel, P.L.C.M., van Erning, L.J.Th.O., Lemmens, J.A.M., van Ruijs, S.H.J., van de Putte, L.B.A. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheum 1992, 31, 91–96.

    Google Scholar 

  17. Sambrook, P.N., Eisman, J.A., Yeates, M.G., Pocock, N.A. Eberl, S., Champion, G.D. Osteoporosis in rheumatoid arthritis: safety of low dose corticoids. Ann of Rheum Dis 1986, 45, 950–953.

    Google Scholar 

  18. Sambrook, P.N., Cohen, M.L., Eisman, J.A., Pocock, N.A., Champion, G.D., Yeates, M.G. Effects of low dose corticosterois on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989, 48, 535–538.

    PubMed  Google Scholar 

  19. Leboff, M.S., Wade, J.P., Maclowiak, S., Fuleihan, G.E.H., Zangari, M., Liang, M.H. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 1991, 18, 339–344.

    PubMed  Google Scholar 

  20. Bijlsma, J.W.J. Bone metabolism in patients with rheumatoid arthritis. Clin Rheumatol 1988, 7, 16–23.

    PubMed  Google Scholar 

  21. Laan, R.F.J.M., van Riel, P.L.C.M., van de Putte, L.B.A. Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 1992, 826–832.

  22. Brown, J.P., Malaval, L., Chapuy, M.C., Delmas, P.D., Edouard, C., Meunier, P.J. Serum Bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984, 5, 1091–1093.

    Google Scholar 

  23. Lems, W.F., Jacobs, J.W.G., van den Brink, H.R., van Rijn, H.J.M., Bijlsma, J.W.J. Transient decrease in osteocalcin and markers of collagen type 1 formation during corticosteroid pulse therapy. Br J Rheum 1993, 32, 787–790.

    Google Scholar 

  24. Kotowicz, M.A., Hall, S., Hunder, G.G., Cedel, S.L., Mann, K.G., Riggs, B.L. Relationship of glucocorticoid dosage to serum bone GLA-protein concentration in patients with rheumatologic disorders. Arthritis Rheum 1990, 10, 1487–1492.

    Google Scholar 

  25. Adachi, J.D. Markers of bone turnover in rheumatoid arthritis. J Rheumatol 1991, 18, 119–120.

    Google Scholar 

  26. Godschalk, M., Downs, R. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Min Res 1988, 3, 113–115.

    Google Scholar 

  27. Mitchell, D.R., Jackson, T.W., Lyles, K.W. Effects of short-term administration of glucocorticoids on bone metabolism in healthy elderly men. J Am Geriatr Soc 39, 1179–1182.

  28. Prummel, M.F., Wiersinga, W.M., Lips, P., Sanders, G.T.B., Sauerwein, H.P. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991, 72, 382–386.

    PubMed  Google Scholar 

  29. Caniggia, A., Nuti, R., Lore, F., Vattimo, A. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochemistry 1981, 15, 153–161.

    Google Scholar 

  30. hahn, T.J., Halstead, L.R., Bran, D.T. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolic concentrations in man. J Clin Endocrinology Metab 1981, 52, 111–115.

    Google Scholar 

  31. Chesney, R.W., Mazess, R.B., Hamstra, A.J., DeLuca, H.F. Reduction of serum- 1,25 dihydroxyvitamin D3 in children receiving glucocorticoids. Lancet 1978, ii, 1123–1125.

    Google Scholar 

  32. Fucik, R.F., Kukreja, S.C., Hargis, G.K., Bowser, E.N., Henderson, W.J., Williams, G.A. Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 1975, 40, 152–156.

    PubMed  Google Scholar 

  33. Seeman, E., Kumar, R., Hunder, G.G., Scott, M., Heath, H., III, Riggs, B.L. Production, degradation and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest 1980, 66, 664–669.

    PubMed  Google Scholar 

  34. Reid, I.R., Ibbertson, H.K. Calcium supplements in the prevention of steroid induced osteoporosis. Am J Clin Nutr 1986, 44, 287–290.

    PubMed  Google Scholar 

  35. Bijlsma, J.W.J., Raymakers, J.A., Mosch, C., Hoekstra, A., Derksen, R.W.H.M., Baart de la Faille H, Duursma, S.A. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol 1988, 6, 113–119.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lems, W.F., Jacobs, J.W.G., Van Rijn, H.J.M. et al. Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers. Clin Rheumatol 14, 420–424 (1995). https://doi.org/10.1007/BF02207675

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207675

Key words

Navigation